Vor Biopharma Inc. (NASDAQ:VOR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Since at least Feb 4, 2021 |
| David Lubner Other companies: Braveheart Bio, Inc. (Director · Since at least Aug 5, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); CARGO Therapeutics, Inc. (Director · Since at least Nov 9, 2023); Arcellx Inc (Director · Since at least Feb 3, 2022); Dyne Therapeutics, Inc. (Board Member · Since at least Jul 31, 2020); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); POINT Biopharma Global Inc (Director · Jul 7, 2020 – Dec 26, 2023 · Past); Nightstar Therapeutics PLC (Director · Jan 1, 2019 – Jun 7, 2019 · Past); Ra Pharmaceuticals Inc (Executive VP and CFO · Oct 25, 2016 – Apr 2, 2020 · Past); Tetraphase Pharmaceuticals Inc (SVP and CFO · Mar 19, 2013 – Aug 14, 2015 · Past) | Director · Feb 4, 2021 – May 22, 2025 · Past |
| Alexander Cumbo Other companies: Stoke Therapeutics, Inc. (Director · Since at least Sep 23, 2026); Climb Bio, Inc. (Director · Since at least Mar 28, 2025); Solid Biosciences Inc. (President and CEO, Director · Since at least Dec 2, 2022); Verve Therapeutics Inc (Director · Since at least Jun 9, 2022); Ra Pharmaceuticals Inc (Director · Nov 14, 2018 – Apr 2, 2020 · Past); Sarepta Therapeutics, Inc. (EVP, Chief Commercial Officer · Mar 5, 2018 – Feb 28, 2020 · Past) | Chair of the Compensation Committee · Since at least Jul 16, 2025 |
| Daniella Beckman Other companies: Upstream Bio, Inc. (Member, Board of Directors · Since at least Oct 10, 2024); Blueprint Medicines Corp (Director · Since at least Dec 8, 2021); Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 10, 2021); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Translate Bio Inc (Director · Jun 18, 2019 – Sep 14, 2021 · Past) | Chair of the Audit Committee · Since at least Feb 4, 2021 |
| Joshua Resnick Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Cidara Therapeutics Inc (Director · Since at least Jan 3, 2025); PepGen Inc. (Director · Since at least Jun 20, 2024); Jade Biosciences, Inc. (Director · Jun 5, 2024 – Jun 5, 2024 · Past) | Director · May 23, 2024 – May 22, 2025 · Past |
| Matthew R Patterson Other companies: 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 14, 2023 · Past); Audentes Therapeutics Inc (Chief Executive Officer, Director · Jul 19, 2016 – Jan 15, 2020 · Past) | Director · Feb 4, 2021 – May 22, 2025 · Past |
| David Zaccardelli Other companies: SAB Biotherapeutics, Inc. (Chair of the Board · Since at least Jan 5, 2026); Verona Pharma plc (President and CEO, Director · Since at least Aug 7, 2024) | Director · Since at least Jul 7, 2026 |
| Jean-Paul Kress Other companies: Biogen Inc. (EVP Pres Int'l & Global Hd GTO · Jun 14, 2017 – Jul 3, 2017 · Past); Sarepta Therapeutics, Inc. (Director · Mar 10, 2017 – Mar 10, 2017 · Past) | Chief Executive Officer and Chairman · Since at least Jun 25, 2025 |
| Peter Kolchinsky Other companies: Artiva Biotherapeutics, Inc. (Director · Since at least Jun 12, 2026); ARS Pharmaceuticals, Inc. (Director · Since at least Sep 30, 2025) | Director · Since at least Apr 2, 2026 |
| Sven Ante Lundberg Other companies: Q32 Bio Inc. (Director · Since at least Mar 25, 2024); CRISPR Therapeutics AG (Chief Scientific Officer · Oct 18, 2016 – Oct 24, 2016 · Past) | Director · Feb 4, 2021 – May 22, 2025 · Past |
| Wouter Joustra Other companies: enGene Therapeutics Inc. (Director · Since at least May 15, 2024); NewAmsterdam Pharma Company N.V. (Director · Jul 16, 2024 – Jul 16, 2024 · Past) | Director · Since at least Dec 18, 2025 |
| Amy Quinlan Other companies: Voyager Therapeutics, Inc. (Principal Accounting Officer · Since at least May 8, 2026) | Vice President of Finance · Jun 21, 2024 – Nov 6, 2024 · Past |
| Andrew David Levin Other companies: Climb Bio, Inc. (Director · Since at least Aug 9, 2021) | Director · Since at least Dec 18, 2025 |
| Dallan Murray Other companies: Sarepta Therapeutics, Inc. (Chief Customer Officer · Apr 24, 2024 – Mar 7, 2025 · Past) | Chief Commercial Officer · Since at least Aug 4, 2025 |
| Eyal C Attar Other companies: Aprea Therapeutics, Inc. (SVP, Chief Medical Officer, Director · Oct 2, 2019 – Jun 3, 2022 · Past) | CHIEF MEDICAL OFFICER · Oct 11, 2022 – Feb 13, 2025 · Past |
| Michel Detheux Other companies: Iteos Therapeutics Inc (Chief Executive Officer, Director · Since at least Jul 23, 2020) | Member of the Audit Committee · Since at least Jul 16, 2025 |
| Nathan D Jorgensen Other companies: Voyager Therapeutics, Inc. (Chief Financial Officer · Since at least Jul 8, 2024) | CHIEF FINANCIAL OFFICER · Feb 4, 2021 – May 6, 2024 · Past |
| Adi Osovsky | General Counsel · Since at least Sep 2, 2025 |
| Carol Lincoln | Head of Human Resources · Since at least Nov 5, 2026 |
| Christopher Slapak | Chief Medical Officer · Feb 4, 2021 – Feb 1, 2022 · Past |
| Erez Kalir | Member of the Audit Committee · Since at least Jan 6, 2025 |
| Fouad Namouni | Chair of the Nominating and Corporate Governance Committee · Since at least Nov 5, 2026 |
| Han Wook Choi | Chief Financial Officer · Sep 30, 2024 – May 1, 2025 · Past |
| Jeremy Sokolove | Chief Medical Officer · Since at least Nov 3, 2025 |
| Navid Z. Khan | Chief Medical Affairs Officer · Since at least Sep 23, 2025 |
| Qing Zuraw | Chief Development Officer · Since at least Jul 17, 2025 |
| Robert Ang | PRESIDENT AND CEO, Director · Nov 6, 2023 – May 6, 2025 · Past |
| Sadik Kassim | Chief Technology Officer · Feb 4, 2021 – Feb 4, 2021 · Past |
| Sandy Mahatme | Chief Financial Officer, Chief Business Officer · Since at least Jul 10, 2025 |
| Sarah Burgess Reed | Director · Since at least Aug 27, 2025 |
| Tirtha Chakraborty | Chief Sci Off & Head Tech Ops · Feb 4, 2021 – May 6, 2025 · Past |